Literature DB >> 23422402

Perospirone normalized P300 and cognitive function in a case of early psychosis.

Yuko Higuchi, Tomiki Sumiyoshi, Toru Ito, Michio Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23422402     DOI： 10.1097/JCP.0b013e318287c527

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

1.  Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Takahiro Tateno; Suguru Nakajima; Daiki Sasabayashi; Shimako Nishiyama; Yuko Mizukami; Tsutomu Takahashi; Michio Suzuki
Journal:  J Pers Med       Date:  2021-04-21

Review 2.  Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects.

Authors:  Tomiki Sumiyoshi; Tomohiro Miyanishi; Tomonori Seo; Yuko Higuchi
Journal:  Front Behav Neurosci       Date:  2013-10-21       Impact factor: 3.558

3.  Mismatch negativity and p3a/reorienting complex in subjects with schizophrenia or at-risk mental state.

Authors:  Yuko Higuchi; Tomonori Seo; Tomohiro Miyanishi; Yasuhiro Kawasaki; Michio Suzuki; Tomiki Sumiyoshi
Journal:  Front Behav Neurosci       Date:  2014-05-13       Impact factor: 3.558

Review 4.  Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response.

Authors:  Kazuki Sueyoshi; Tomiki Sumiyoshi
Journal:  Front Psychiatry       Date:  2018-06-13       Impact factor: 4.157

5.  Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with Differentiation.

Authors:  Xiaohui Hu; Masaya Ono; Nyam-Osor Chimge; Keisuke Chosa; Cu Nguyen; Elizabeth Melendez; Chih-Hong Lou; Punnajit Lim; John Termini; Keane K Y Lai; Patrick T Fueger; Jia-Ling Teo; Yusuke Higuchi; Michael Kahn
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

6.  Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.

Authors:  Suguru Nakajima; Yuko Higuchi; Takahiro Tateno; Daiki Sasabayashi; Yuko Mizukami; Shimako Nishiyama; Tsutomu Takahashi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

Review 7.  Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia.

Authors:  Tomiki Sumiyoshi; Yuko Higuchi; Takashi Uehara
Journal:  Front Behav Neurosci       Date:  2013-10-16       Impact factor: 3.558
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.